Skip to main content
Equibles

Sriram Ryali

CFO

Caribou Biosciences, Inc. (CRBU)

Equibles does not estimate personal net worth.

Get an email with a short summary when Caribou Biosciences, Inc. publishes a filing, an earnings call transcript or a press release.

Get CRBU alerts

About Sriram Ryali

Sriram Ryali is recorded as CFO at Caribou Biosciences, Inc. (CRBU). The newest filing on record that lists Sriram Ryali as CFO at Caribou Biosciences, Inc. (CRBU) is dated April 24, 2026. Caribou Biosciences, Inc. reported in an 8-K filed January 2, 2025 that Sriram Ryali was appointed Chief Financial Officer ("CFO"), effective January 2, 2025. The proxy statement of Caribou Biosciences, Inc. reports total compensation of $1,029,413 for Sriram Ryali in fiscal 2025, including a base salary of $483,163. Caribou Biosciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Caribou Biosciences, Inc. includes Rachel Haurwitz (CEO and Board Member), Tim Kelly (CTO), Jason V. O'Byrne (Chief Accounting Officer) and 7 others.

“On January 2, 2025, Caribou Biosciences, Inc., a Delaware corporation (the "Company"), announced the appointment of Sriram Ryali, age 44, to the position of Chief Financial Officer ("CFO") of the Company, effective as of January 2, 2025 (the "Start Date").”
Caribou Biosciences, Inc. Form 8-K, filed January 2, 2025 · Read the filing

Affiliation history

Company network

Leadership on record at Caribou Biosciences, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Caribou Biosciences, Inc. (CRBU) $483,163 $1,029,413

Recent activity